Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. Danielle Schlosser PhD appointed Senior Vice-President, Clinical Innovation, to lead therapist research and training, bringing her clinical experience in behavioural health and expertise in digital health innovation. Business highlights.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. This disconnect is commonly referred to as the placebo effect.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Veriheal

MAY 16, 2022

Nicknamed “K,” “special K,” “cat valium,” and “vitamin K,” ketamine is also commonly referred to as “horse tranquilizer.” At the current time, researchers are busy carrying out a small-scale Phase I clinical trial into ketamine for PD.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. References Staff, T. 2019) Cannabis may help relieve Autism symptoms, Israeli study shows.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

JULY 7, 2021

We remain encouraged as we continue our evaluations of MYMD-1 for efficacy and safety – especially as studies continue to suggest we may be able to address many of the concerns that are associated with the current drugs on the market today in these disease areas.”. President, Director and Chief Medical Officer of MyMD. “We

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Cannabis Law Report

JULY 28, 2021

The ideal RPS has a strong technical background and is comfortable learning and navigating the online systems unique to various regulatory agencies, as well as other specialized technologies for research, clinical trials and project management. Experience working for a clinical study Sponsor.

Clinical Trials 81

Clinical Trials Research and Development Data Environment 81

Canna Care Docs

OCTOBER 3, 2023

Palliative Care and Symptom Management Referred to as palliative care, this medical caregiving approach helps to maximize the quality of life for patients and mitigate any physical or emotional suffering among people with serious and complex terminal illnesses.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

MMJ Recs

JULY 9, 2024

Medical Marijuana: An Overview Medical marijuana refers to the use of cannabis and its cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), for medicinal purposes. Some clinical trials have shown that cannabinoids, particularly THC and CBD, effectively reduce muscle spasticity and pain in MS patients.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

MAY 6, 2021

3 It has less of an affinity to endocannabinoid receptors, however, which is likely why it causes more moderate effects — and why delta-8 is often referred to as “weed light.” When it comes to safety, the two main factors to consider are production (standards and regulation) and research. Is delta-8-THC safe to use?

THC 145

THC Cannabinoids Concentrates Hemp 145

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.”

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 124

Research and Development Data THC Clinical Trials 124

Cannabis Law Report

JULY 28, 2021

Cepharanthine is on its way to establishing itself as a once per day, oral anti-cancer therapeutic with a well-established safety profile which will pave the way for an expedited clinical development pathway and future partnering opportunities with pharmaceutical companies. References: Yasuda, K., ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

OCTOBER 13, 2021

Vigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

MMJ Recs

NOVEMBER 30, 2023

Medical Marijuana for Epilepsy Treatment Medical marijuana, often referred to as MMJ, is a term used to describe the use of cannabis and its derivatives for therapeutic purposes. Clinical trials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 45

Policy Safety Marijuana Data 45

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.

Sleep 111

Sleep Treatment Research and Development Therapy 111

MMJ Recs

JULY 17, 2024

Medical marijuana refers to the use of cannabis and its cannabinoids to treat medical conditions, including the side effects of chemotherapy. Clinical trials have highlighted the efficacy of medical marijuana in managing pain, suggesting it as a potential alternative or adjunct to traditional pain medications.

Marijuana 52

Marijuana Treatment Patients Therapy 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. References. Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 98

CBD THC Conditions Medicine 98

MMJ Recs

JULY 3, 2024

Stress, on the other hand, refers to the body’s response to external pressures or demands. For qualifying patients, staying informed about local regulations through state health department resources and reputable CBD retailers is essential to ensure compliance and safety. Image by Suzy Hazelwood on Pexels.

CBD 52

CBD Research and Development Clinical Trials THC 52

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. References Staff, T. 2019) Cannabis may help relieve Autism symptoms, Israeli study shows.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

JANUARY 11, 2019

However, we firmly disagree that the referenced clinical trials are in fact “substantial,” as the trials were extremely limited in scope, and funding and the publication of these trials were limited. CBD has been found to be generally well tolerated with a good safety profile.”.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. All items referring to medicinal cannabis were included. A recent study by Lintzeris et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

MMJ Recs

AUGUST 1, 2024

Medical marijuana, through its appetite-stimulating effects (often referred to as “the munchies”), can combat this condition. Safety and Side Effects of Medical Marijuana While medical marijuana delivers many benefits, it still has potential side effects.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. References. [1] Numerous studies have shown that CBD is a safe, non-impairing, and non-habit-forming substance.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. In denying the claim for medical marijuana, the court distinguished Joinson v. In rejecting the claim, the court cited Torchia v. ” 42.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The trial was conducted as a multiple ascending dose (MAD) study. The average age was 80.9

Clinical Trials 40

Clinical Trials Safety Data Patients 40

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45

Safety CBD Clinical Trials Oil 45

Veriheal

SEPTEMBER 21, 2023

However, it is also commonly referred to as the Colorado River toad. The toad’s secretion has been referred to as “the most potent psychedelic toad venom on Earth.” The Sonoran Desert Psychedelic Toad The Sonoran desert toad got its name from where it is believed to be common – the Sonoran Desert.

Clinical Trials 116

Clinical Trials Therapy Conditions Pets 116

The Cannigma

DECEMBER 12, 2022

Many psychedelics are also referred to as entheogens, which are substances that expand consciousness for religious or spiritual purposes. This decrease in DMN activity from psychedelics is sometimes referred to as “ego death,” and can be therapeutic to reset unhealthy thought patterns, almost like a brain reboot.

History 140

History Microdosing Research and Development Clinical Trials 140

MMJ Recs

APRIL 1, 2024

Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. While CBD can be derived from both hemp and marijuana plants, medical marijuana typically refers to cannabis strains containing higher levels of THC.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

The Cannigma

APRIL 8, 2021

They can only refer you, and then you get sent to someone with potentially just a high school education. I read an op-ed or a column in the New York Times a few weeks ago that totally blew my mind, where this person was basically arguing that we don’t have enough safety information about cannabis in order to be legalizing it everywhere.

Medicine 133

Medicine Cannabinoids Cannabis THC 133

Alchimia

FEBRUARY 1, 2022

To date, there are several studies that have tried to verify the safety and toxicology of CBD when it is administered to treat certain diseases. Some of the participants in such studies, such as the one conducted to determine the safety and effectiveness of CBD in treating epilepsy , reported the following side effects: Diarrhea.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Cannabis Law Report

SEPTEMBER 24, 2019

We’re presuming both names “Epidyolex” & “Epidiolex” refer to exactly the same product and the former is the US product name and the latter the European brand name. Here is the BBC report and below you will find the full press release from GW Pharmaceuticals.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55